These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
    Author: Wolthers OD, Høst A, Frederiksen B, Halken S.
    Journal: Ugeskr Laeger; 2012 Aug 27; 174(35):1989-92. PubMed ID: 22929576.
    Abstract:
    Specific immunotherapy is the only current treatment that may modify the disease process in allergic rhinoconjunctivitis. Recent studies have evidenced that sublingual administration of grass extract tablets is an efficacious, safe and convenient form of specific immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis. It is recommended that daily treatment is initiated four months before the pollen season begins and continued through three years, though paediatric studies of long-term and potential asthma and allergy prevention effects are still awaited.
    [Abstract] [Full Text] [Related] [New Search]